4//SEC Filing
Corvus Pharmaceuticals, Inc. 4
Accession 0001140361-16-089148
$CRVSCIK 0001626971operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 7:06 PM ET
Size
5.5 KB
Accession
0001140361-16-089148
Insider Transaction Report
Form 4
Verner Erik J.
V.P., Chemistry Research
Transactions
- Award
Stock Option (Right to Buy)
2016-12-07+25,000→ 25,000 totalExercise: $16.37Exp: 2026-12-07→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-forty-eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 7, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001626971
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 7:06 PM ET
- Size
- 5.5 KB